Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1

Nature Communications

Volumn 5, Issue , 2014, Pages

  Ma, Xiaoyu ^a   Li, Chenchen ^a   Sun, Linchong ^a   Huang, De ^a   Li, Tingting ^a   He, Xiaoping ^a   Wu, Gongwei ^a   Yang, Zheng ^a   Zhong, Xiuying ^a   Song, Libing ^b   Gao, Ping ^a   Zhang, Huafeng ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIN28B PROTEIN, HUMAN; MICRORNA; MIRNLET7 MICRORNA, HUMAN; OXYGEN; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; RNA BINDING PROTEIN;

CANCER; GENE EXPRESSION; GERM CELL; GLUCOSE; HYPOXIA; METABOLISM; OXYGEN;

ARTICLE; CANCER CELL LINE; CANCER GROWTH; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; DISEASE COURSE; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DISEASE PROGRESSION; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICRORNAS; NEOPLASMS; OXYGEN; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS;

EID: 84923025327     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6212     Document Type: Article

References (38)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
2. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
3. Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472-482 (2008).
4. Zhu, H. et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 147, 81-94 (2011).
5. Guo, Y. et al. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384, 51-61 (2006).
6. Viswanathan, S. R. et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 41, 843-848 (2009).
7. Wang, Y. C. et al. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 31, 1516-1522 (2010).
8. Polesskaya, A. et al. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 21, 1125-1138 (2007).
9. West, J. A. et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 460, 909-913 (2009).
10. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
11. Abbott, A. L. et al. The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev. Cell. 9, 403-414 (2005).
12. Ambros, V. & Horvitz, H. R. Heterochronic mutants of the nematode Caenorhabditis elegans. Science 226, 409-416 (1984).
13. Moss, E. G., Lee, R. C. & Ambros, V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88, 637-646 (1997).
14. Nimmo, R. A. & Slack, F. J. An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma 118, 405-418 (2009).
15. Molenaar, J. J. et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat. Genet. 44, 1199-1206 (2012).
16. Peng, S. et al. Genome-wide studies reveal that Lin28 enhances the translation of genes important for growth and survival of human embryonic stem cells. Stem Cells 29, 496-504 (2011).
17. Shyh-Chang, N. et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 339, 222-226 (2013).
18. Shyh-Chang, N. et al. Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell 155, 778-792 (2013).
19. Dang, C. V. MYC on the path to cancer. Cell 149, 22-35 (2012).
20. Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. & Kaelin, Jr W. G. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237-246 (2002).
21. Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732 (2003).
22. Kaelin, W. G. Von Hippel-Lindau disease. Annu. Rev. Pathol. 2, 145-173 (2007).
23. Zhang, H. et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420 (2007).
24. Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177-185 (2006).
25. Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L. & Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197 (2006).
26. Gao, P. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-765 (2009).
27. Viswanathan, S. R., Daley, G. Q. & Gregory, R. I. Selective blockade of microRNA processing by Lin28. Science 320, 97-100 (2008).
28. Holness, M. J. & Sugden, M. C. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem. Soc. Trans. 31, 1143-1151 (2003).
29. Shinoda, G. et al. Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism. Stem Cells 31, 1563-1573 (2013).
30. Bonnet, S. et al. A mitochondria-K\+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37-51 (2007).
31. Takubo, K. et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 12, 49-61 (2013).
32. Kim, J. W., Gao, P., Liu, Y. C., Semenza, G. L. & Dang, C. V. Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 27, 7381-7393 (2007).
33. Ji, H. K. et al. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE 6, e26057 (2011).
34. Chang, T. C. et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl Acad. Sci. USA 106, 3384-3389 (2009).
35. Kwiatkowski, Jr T.J. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 (2009).
36. Zhang, W. C. et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148, 259-272 (2012).
37. Boyerinas, B. et al. Identification of let-7-regulated oncofetal genes. Cancer Res. 68, 2587-2591 (2008).
38. Peter, M. E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8, 843-852 (2009).